Τόμος 27 (2009) – Τεύχος 1 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 27 (2009) – Issue 1– Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Παναγιώτης Ακριτόπουλος^1,2, Παρασκευή Παπαϊωαννίδου¹, Ιπποκράτης Χατζώκος², Αφροδίτη Χαριτάντη³, Ειρήνη Ιωσηφίδου², Μαρία Κωτούλα¹, Βασιλική Μήρτσου¹

¹Εργαστήριο Φαρμακολογίας, ²Α΄ Ορθοπαιδική Κλινική, ³Εργαστήριο Ακτινολογίας, Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης, Θεσσαλονίκη

Panagiotis Akritopoulos¹, Paraskevi Papaioannidou¹, Ippokratis Hatzokos², Αfrodite Haritanti³, Eirine Iosifidou², Maria Kotoula¹, Vasiliki Mirtsou-Fidani¹

¹Department of Pharmacology, ²ST Department of Orthopedics, ³Department of Radiology, Faculty of Medicine, Aristotle University, Thessaloniki, Hellas

2. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., O’Keefe R.J.: Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblasts lineage and is critically involved in bone repair. Clin. Investig. 109: 1405-1415 (2002)

3. Altman R.D., Latta L.L., Keer R., Renfree K., Hornicek F.J., Banovac K.: Effect of nonsteroidal anti-inflammatory drugs on fracture healing: a laboratory study in rats. J. Orthop. Trauma 9: 392-400 (1995)

4. Carano R.A., Filvaroff E.H.: Angiogenesis and bone repair. Drug Discov. Today 8: 980-989 (2003)

5. Tsiridis E., Upadhyay N., Giannoudis P.: Molecular aspects of fracture healing: which are the important molecules? Injury 38(Suppl. 1): S11-S25 (2007)

6. Gerstenfeld L.C., Thiede M., Seibert K., Mielke C., Phippard D., Svarg B., Cullinane D., Einhorn T.A.: Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal antiinflammatory drugs. J. Orthop. Res. 21: 670-675 (2003)

7. Endo K., Sairo K., Komatsubara S., Sasa T., Egawa H., Yonekura D. et al.: Cyclooxygenase-2 inhibitor inhibits the fracture healing. J. Physiol. Anthropol. 21: 235-238 (2002)

8. Goodman S., Ma T., Trindade M., Ikenoue T., Matsuura I., Wong N. et al.: COX-2 selective NSAIDS decrease bone ingrowth in vivo. J. Orthop. Res. 20: 1164-1169 (2002)

9. Leonelli S.M., Goldberg B.A., Safanda J., Bagwe M.R., Sethuratnam S., King S.J.: Effects of a cyclooxygenase-2 inhibitor (rofecoxib) on bone healing. Am. J. Orthop. 35: 79-84 (2006)

10. Gerstenfeld L.C., Al-Ghawas M., Alkhiary Y.M., Cullinane D.M., Krall E.A., Fitch J.L., Webb E.G., Thiede M.A.: Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J. Bone Joint Surg. Am. 89: 114-125 (2007)

11. Akritopoulos P., Papaioannidou P., Hatzokos I., Haritanti A., Iosifidou E., Kotoula M., Mirtsou-Fidani V.: Parecoxib has non-significant long-term effects on bone healing in rats when administered for a short period after fracture. Arch. Orthop. Trauma Surg. DOI 10.1007/s00402-008-0707-6 (2008)

12. Beck A., Krischak G., Sorg T., Augat P., Farker K., Merkel U., Kinzl L., Claes L.: Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch. Orthop. Trauma Surg. 123: 327-332 (2003)

13. Riew K.D., Long J., Rhee J., Lewis S., Kuklo T., Kim Y.J., Yukawa Y., Zhy Y.: Time-dependent inhibitory effects of indomethacin on spinal fusion. J. Bone Joint Surg. Am. 85: 632-634 (2003)

14. Long J., Lewis S., Kuklo T., Zhu Y., Riew K.D.: The effect of cyclooxygenase-2 inhibitors on spinal fusion. J. Bone Joint Surg. Am. 84: 1763-1768 (2002)

15. Mullins B., Copeland S., Weinhold P., et al: Effect on fracture healing in a mouse model. 48th Annual Meeting of Orthopaedic Research Society; Dallas, USA (2002)

16. Brown K.M., Saunders M.M., Kirsch T., Donahue H.J., Reid J.S.: Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J. Bone Joint Surg. Am. 86: 116–123 (2004)

17. Kessler W., KirchoV.C., Reeh P.W., Handwerker H.O.: Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance. Exp. Brain Res. 91: 467-476 (1992)

18. Reuben S., Connelly N.: Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth. Analg. 91: 1221-1225 (2000)

19. Lipsky P.E.: The role of COX-2-specific inhibitors in clinical practice. Am. J. Med. 110: 1S-2S (2001)

20. Schug S.A.: The role of COX-2 inhibitors in the treatment of postoperative pain. Biomed. Pharmacother. 60: 323-328 (2006)

21. Reddy B.S., Rao C.V.: Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs. Drugs Aging 16: 329–34 (2000)

22. Gately S., Li W.W.: Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin. Oncol. 31(2 Suppl 7): 2-11 (2004)

23. Wu G., Luo J., Rana J.S., Laham R., Sellke F.W., Li J.: Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc. Res. 69: 512-519 (2006)

24. Augustin G., Antabak A., Davila S.: The periosteum. Part 1: anatomy, histology and molecular biology. Injury 38: 1115-1130 (2007)

25. FitzGerald G.A., Patrono C.: The coxibs, selective inhibitors of cyclooxygenase. N. Engl. J. Med. 345: 433-442 (2001)

26. Gajraj N.M.: The effect of cyclooxygenase-2 inhibitors on bone healing. Reg. Anesth. Pain Med. 28: 456-465 (2003)

27. Aspenberg P.: Avoid COX inhibitors after skeletal injury! Acta Orthop Scand 73: 489-490 (2002)

28. Einhorn T.A.: COX-2: where are we in 2003? The role of cyclooxygenase-2 in bone repair. Arthritis Res. Ther. 5: 5-7 (2003)

29. Dahners L.E., Mullis B.H.: Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft tissue healing. J. Am. Acad. Orthop. Surg. 12: 139-143 (2004)